Association not causation

Archives of Internal Medicine

Volumn 169, Issue 11, 2009, Pages 1079-

  Golomb, Beatrice A ^a   Koperski, Sabrina ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE;

CLINICAL RESEARCH; COGNITION; HUMAN; LETTER; MEDICAL LITERATURE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLICATION; SURVIVAL; UNSPECIFIED SIDE EFFECT;

CAUSALITY; CORONARY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PATIENT COMPLIANCE;

EID: 67249157640     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med. 2009;169(3):260-268.
2. Smits CH, Deeg DJ, Kriegsman DM, Schmand B. Cognitive functioning and health as determinants of mortality in an older population. Am J Epidemiol. 1999;150(9):978-986. (Pubitemid 29508651)
3. Stilley CS, Sereika S, Muldoon MF, Ryan CM, Dunbar-Jacob J. Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med. 2004;27(2):117-124. (Pubitemid 38364891)
4. Friedman HS, Tucker JS, Schwartz JE, et al. Childhood conscientiousness and longevity: health behaviors and cause of death. J Pers Soc Psychol. 1995;68(4):696-703.
5. Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8(6):373-418.
6. Bruckert E, Simonetta C, Giral P; CREOLE Study Team. Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia. J Clin Epidemiol. 1999;52(6):589-594. (Pubitemid 29284819)
7. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med. 1980;303(18):1038-1041. (Pubitemid 10025214)